Last updated: March 1, 2023
Sponsor: Inha University Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Schizophrenia And Schizoaffective Disorders
Tourette's Syndrome
Schizophrenia And Schizoaffective Disorders (Pediatric)
Treatment
N/AClinical Study ID
NCT05764148
2021-01-026
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients who have received a primary diagnosis of schizophrenia
- Patients who are at least 18 years old and under 65 years old
- Patients who show a score of 3 or higher on at least two negative symptom items in thePositive and Negative Syndrome Scale (PANSS)
- The subject selection period is until December 31, 2021, from the IRB approval date.
Exclusion
Exclusion Criteria:
- Patients with a history of organic brain syndrome, epilepsy, or traumatic brain injury
- Patients with comorbidities such as intellectual disability, current alcohol or othersubstance dependence
- Patients who show a score of 5 or higher on at least two positive symptom items in thePositive and Negative Syndrome Scale (PANSS)
- Patients who have received a diagnosis of major depressive disorder according to theDSM-V criteria by a specialist in psychiatry
- Patients who have received psychological services including components of behavioralactivation therapy
- Patients who are at risk of self-harm or harm to others.
Study Design
Total Participants: 80
Study Start date:
March 01, 2021
Estimated Completion Date:
December 31, 2023
Connect with a study center
Inha university hospital
Incheon, Jung-Gu 22332
Korea, Republic ofActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.